|
1
|
Ferlay J, Soerjomataram I, Ervik M,
Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and
Bray F: Globocan 2012: Estimated cancer incidence, mortality and
prevalence worldwide in 2012 v1.0. IARC CancerBase. (11): IARC,
Lyon. 2014, http://globocan.iarcfr
|
|
2
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates.
CancerEpidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar
|
|
3
|
World Cancer Research Fund, American
Institute for Cancer Research Imperial College, London, . WCRF/AICR
Systematic Literature Review Continuous Update Project Report: The
Associations between Food, Nutrition and Physical Activity and the
Risk of Colorectal Cancer. https://www.wcrf.org/sites/default/files/SLR_colorectal_cancer_2010.pdfOctober.
2010
|
|
4
|
Bishehsari F, Mahdavinia M, Vacca M,
Malekzadeh R and Mariani-Costantini R: Epidemiological transition
of colorectal cancer in developing countries: Environmental
factors, molecular pathways, and opportunities for prevention.
World J Gastroenterol. 20:6055–6072. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Migliore L, Migheli F, Spisni R and
Coppedè F: Genetics, cytogenetics, and epigenetics of colorectal
cancer. J Biomed Biotechnol. 2011:7923622011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peters U, Jiao S, Schumacher FR, Hutter
CM, Aragaki AK, Baron JA, Berndt SI, Bézieau S, Brenner H,
Butterbach K, et al: Colon cancer family registry and the genetics
and epidemiology of colorectal cancer consortium: Identification of
genetic susceptibility loci for colorectal tumors in a genome-wide
meta-analysis. Gastroenterology. 144:799–807. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng Y, Yi R and Cullen BR: MicroRNAs and
small interfering RNAs can inhibit mRNA expression by similar
mechanisms. Proc Natl Acad Sci USA. 100:9779–9784. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zeng Y, Wagner EJ and Cullen BR: Both
natural and designed micro RNAs can inhibit the expression of
cognate mRNAs when expressed in human cells. Mol Cell. 9:1327–1333.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chin LJ, Ratner E, Leng S, Zhai R, Nallur
S, Babar I, Muller RU, Straka E, Su L, Burki EA, et al: A SNP in a
let-7 microRNA complementary site in the KRAS 3′ untranslated
region increases non-small cell lung cancer risk. Cancer Res.
68:8535–8540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brendle A, Lei H, Brandt A, Johansson R,
Enquist K, Henriksson R, Hemminki K, Lenner P and Försti A:
Polymorphisms in predicted microRNA-binding sites in integrin genes
and breast cancer: ITGB4 as prognostic marker. Carcinogenesis.
29:1394–1399. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fang J, Feng Q, Ketel CS, Wang H, Cao R,
Xia L, Erdjument-Bromage H, Tempst P, Simon JA and Zhang Y:
Purification and functional characterization of SET8, a nucleosomal
histone H4-lysine 20-specific methyltransferase. Curr Biol.
12:1086–1099. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nishioka K, Rice JC, Sarma K,
Erdjument-Bromage H, Werner J, Wang Y, Chuikov S, Valenzuela P,
Tempst P, Steward R, et al: PR-Set7 is a nucleosome-specific
methyltransferase that modifies lysine 20 of histone H4 and is
associated with silent chromatin. Mol Cell. 9:1201–1213. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu S, Wang W, Kong X, Congdon LM, Yokomori
K, Kirschner MW and Rice JC: Dynamic regulation of the PR-Set7
histone methyltransferase is required for normal cell cycle
progression. Genes Dev. 24:2531–2542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tardat M, Murr R, Herceg Z, Sardet C and
Julien E: PR-Set7-dependent lysine methylation ensures genome
replication and stability through S phase. J Cell Biol.
179:1413–1426. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jorgensen S, Elvers I, Trelle MB, Menzel
T, Eskildsen M, Jensen ON, Helleday T, Helin K and Sorensen CS: The
histone methyltransferase SET8 is required for S-phase progression.
J Cell Biol. 179:1337–1345. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Abbas T, Shibata E, Park J, Jha S, Karnani
N and Dutta A: CRL4(Cdt2) regulates cell proliferation and histone
gene expression by targeting PR-Set7/Set8 for degradation. Mol
Cell. 40:9–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huen MS, Sy SM, van Deursen JM and Chen J:
Direct interaction between SET8 and proliferating cell nuclear
antigen couples H4-K20 methylation with DNA replication. J Biol
Chem. 283:11073–11077. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dulev S, Tkach J, Lin S and Batada NN:
SET8 methyltransferase activity during the DNA double-strand break
response is required for recruitment of 53BP1. EMBO Rep.
15:1163–1174. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang F, Sun L, Li Q, Han X, Lei L, Zhang H
and Shang Y: SET8 promotes epithelial-mesenchymal transition and
confers TWIST dual transcriptional activities. EMBO J. 31:110–123.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang C, Guo Z, Wu C, Li Y and Kang S: A
polymorphism at the miR-502 binding site in the 3′ untranslated
region of the SET8 gene is associated with the risk of epithelial
ovarian cancer. Cancer Genet. 205:373–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ding C, Li R, Peng J, Li S and Guo Z: A
polymorphism at the miR-502 binding site in the 3′ untranslated
region of the SET8 gene is associated with the outcome of
small-cell lung cancer. Exp Ther Med. 3:689–692. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo Z, Wu C, Wang X, Wang C, Zhang R and
Shan B: A polymorphism at the miR-502 binding site in the
3′-untranslated region of the histone methyltransferase SET8 is
associated with hepatocellular carcinoma outcome. Int J Cancer.
131:1318–1322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Diao L, Su H, Wei G, Li T, Gao Y, Zhao G
and Guo Z: Prognostic value of microRNA 502 binding site SNP in the
3′-untranslated region of the SET8 gene in patients with
non-Hodgkin's lymphoma. Tumori. 100:553–558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi X, Kachirskaia I, Yamaguchi H, West
LE, Wen H, Wang EW, Dutta S, Appella E and Gozani O: Modulation of
p53 function by SET8-mediated methylation at lysine 382. Mol Cell.
27:636–646. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Dhami GK, Liu H, Galka M, Voss C, Wei R,
Muranko K, Kaneko T, Cregan SP, Li L and Li SS: Dynamic methylation
of Numb by Set8 regulates its binding to p53 and apoptosis. Mol
Cell. 50:565–576. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Landi D, Gemignani F, Naccarati A, Pardini
B, Vodicka P, Vodickova L, Novotny J, Forsti A, Hemminki K, Canzian
F and Landi S: Polymorphisms within micro-RNA-binding sites and
risk of sporadic colorectal cancer. Carcinogenesis. 29:579–584.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gao Y, He Y, Ding J, Wu K, Hu B, Liu Y, Wu
Y, Guo B, Shen Y, Landi D, et al: An insertion/deletion
polymorphism at miRNA-122-binding site in the interleukin-1alpha 3′
untranslated region confers risk for hepatocellular carcinoma.
Carcinogenesis. 30:2064–2069. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Horikawa Y, Wood CG, Yang H, Zhao H, Ye Y,
Gu J, Lin J, Habuchi T and Wu X: Single nucleotide polymorphisms of
microRNA machinery genes modify the risk of renal cell carcinoma.
Clin Cancer Res. 14:7956–7962. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, et al: Genetic variants of miRNA
sequences and non-small cell lung cancer survival. J Clin Invest.
118:2600–2608. 2008.PubMed/NCBI
|
|
33
|
Song F, Zheng H, Liu B, Wei S, Dai H,
Zhang L, Calin GA, Hao X, Wei Q, Zhang W and Chen K: An
miR-502-binding site single-nucleotide polymorphism in the
3′-untranslated region of the SET8 gene is associated with early
age of breast cancer onset. Clin Cancer Res. 19:6292–6300. 2009.
View Article : Google Scholar
|
